Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000456716 | SCV000558354 | likely benign | Ataxia-telangiectasia syndrome | 2024-11-24 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001178394 | SCV001342832 | likely benign | Hereditary cancer-predisposing syndrome | 2017-01-12 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001293473 | SCV001482046 | likely benign | not specified | 2024-12-16 | criteria provided, single submitter | clinical testing | Variant summary: ATM c.2838+9C>T alters a non-conserved nucleotide located at a position not widely known to affect splicing. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 2.4e-05 in 251112 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.2838+9C>T in individuals affected with Breast Cancer and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 414559). Based on the evidence outlined above, the variant was classified as likely benign. |
Myriad Genetics, |
RCV004591353 | SCV005084748 | likely benign | Familial cancer of breast | 2024-05-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
Prevention |
RCV004551550 | SCV004762119 | likely benign | ATM-related disorder | 2023-05-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |